Disbursements

IFFIm has delivered on its goal to frontload, disbursing US$ 2.6 billion to support vaccine purchase and delivery to 71 developing countries

Gavi has led the effort to vaccinate close to 640 million children in the 2000–2016 period, saving more than nine million lives in the long term. Without IFFIm funds, this would not have been possible.

In total, US$ 2.6 billion has already been disbursed to support vaccine purchase and delivery to 71 developing countries.

 

Breakthrough vaccines

In addition, IFFIm has been instrumental in helping Gavi fund breakthrough vaccines quickly and securely.

For instance, IFFIm financed more than 90% of Gavi's promised payment to UNICEF to secure initial doses of pentavalent, a single shot of which immunises against five infectious diseases: diphtheria, tetanus, pertussis, haemophilus influenzae type B (Hib) and hepatitis B.

Gavi could not have made that promise, including upfront cash payments, without its ability to rely on long-term, stable funding from IFFIm.

US$ 1 = US$ 18

A study in Health Affairs covering 73 Gavi-supported countries over the 2011–2020 period shows that, for every US$ 1 spent on immunisation, US$ 18 are saved in healthcare costs, lost wages and lost productivity due to illness. If we take into account the broader benefits of people living longer, healthier lives, the return on investment rises to US$ 48 per US$ 1 spent.

Ozawa S, Clark S, Portnoy A et al. Return on investment from childhood immunizations in low- and middle-income countries, 2011-20, Health Affairs 2016.

More facts...

close icon

modal window here